Miller Mary sold ACRV
August 18, 2026 · Form 4 insider transaction
Miller Mary sold 185 shares of Acrivon Therapeutics, Inc. at $2.01 per share, a transaction worth $371.85. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
185
Price
$2.01
Total value
$371.85
InsiderMiller Mary
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 18, 2026
Filing dateAugust 20, 2026
Shares owned after82,009
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares sold automatically to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.